StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Crinetics Pharmaceuticals, Inc.
NasdaqGS:CRNX
Sector
Industries
Location
Market Cap
USD 3.09 B
Share Price
USD 33.02
Avg Daily Volume
812,568
Change (1 day)
3.41%
Change (1 year)
-38.48%
Change (YTD)
-35.42%
Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2025: USD 586.83 M
Crinetics Pharmaceuticals, Inc. Common Stock Issued is USD 586.83 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -21.99% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
-
Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 752.23 M, a 529.07% change year over year.
-
Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 119.58 M, a -52.42% change year over year.
-
Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 251.32 M, a 607.29% change year over year.
-
Crinetics Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 35.53 M, a 442.24% change year over year.
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%
Key Data
| Date | Common Stock Issued | Common Stock Repurchased | Free Cash Flow | Operating Cash Flow |
|---|
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%